Dark Forest Capital Management’s Ibere Pharmaceuticals IBER Stock Holding History

Dark Forest Capital Management’s Portfolio IBER Stock Details IBER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,574	Closed	-$157K	–	1650
2022 Q4	$157K	Hold	15,574	–	–	0.04%	298
2022 Q3	$154K	Sell	15,574 -6,039	-28%	-$59.6K	0.03%	416
2022 Q2	$212K	Sell	21,613 -22,831	-51%	-$224K	0.04%	296
2022 Q1	$436K	Sell	44,444 -52,296	-54%	-$509K	0.1%	239
2021 Q4	$940K	Buy	96,740 +52,027	+116%	+$506K	0.35%	78
2021 Q3	$433K	Buy	+44,713	New	+$432K	0.15%	136

Dark Forest Capital Management's IBER Position: Q1 2023 in Review

Dark Forest Capital Management sold out of Ibere Pharmaceuticals (IBER) in Q1 2023, closing a stake of 15,574 shares — an estimated $157K sold.

Dark Forest Capital Management first reported a position in IBER in Q3 2021 and held it in 6 quarters. The position peaked at $940K in Q4 2021. 0 funds tracked by Wall St. Rank hold IBER as of Q1 2023.

Dark Forest Capital Management reported no remaining Ibere Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Dark Forest Capital Management sold 15,574 Ibere Pharmaceuticals shares in Q1 2023, an estimated $157K.
Dark Forest Capital Management first reported a position in Ibere Pharmaceuticals in Q3 2021 and held it in 6 quarters.
Dark Forest Capital Management's Ibere Pharmaceuticals position peaked at $940K in Q4 2021.
0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q1 2023.

Based on Dark Forest Capital Management's 13F filing for Q1 2023, filed 12 May 2023.